Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

NCT: NCT05082077 · ENROLLING_BY_INVITATION

NCT IDNCT05082077
StatusENROLLING_BY_INVITATION
Start Date2022-03-15
Completion2028-01
SponsorParagonix Technologies (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

Frequently Asked Questions

What is Global Utilization And Registry Database for Improved preservAtion of doNor Livers?

Global Utilization And Registry Database for Improved preservAtion of doNor Livers is a clinical trial registered under NCT05082077. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT05082077?

The current status of NCT05082077 (Global Utilization And Registry Database for Improved preservAtion of doNor Livers) is: ENROLLING_BY_INVITATION.

When did Global Utilization And Registry Database for Improved preservAtion of doNor Livers start?

Global Utilization And Registry Database for Improved preservAtion of doNor Livers started on 2022-03-15.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.